{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:38:58Z","timestamp":1781044738343,"version":"3.54.1"},"reference-count":43,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.3892\/mmr.2016.5754","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T08:01:44Z","timestamp":1474358504000},"page":"4360-4366","source":"Crossref","is-referenced-by-count":21,"title":["\u03b1-lipoic acid exerts neuroprotective effects on neuronal cells by upregulating the expression of PCNA via the P53 pathway in neurodegenerative conditions"],"prefix":"10.3892","volume":"14","author":[{"given":"Da-Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Di","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Yao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,9,20]]},"reference":[{"key":"key20180108030128_b1-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"key":"key20180108030128_b2-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.1997.69031196.x","article-title":"Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra","volume":"69","author":"Alam","year":"1997","journal-title":"J Neurochem"},{"key":"key20180108030128_b3-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1073\/pnas.96.10.5774","article-title":"Poly (ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism","volume":"96","author":"Mandir","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108030128_b4-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cell.2007.05.003","article-title":"PCNA, the maestro of the replication fork","volume":"129","author":"Moldovan","year":"2007","journal-title":"Cell"},{"key":"key20180108030128_b5-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrm3562","article-title":"Regulation of PCNA-protein interactions for genome stability","volume":"14","author":"Mailand","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180108030128_b6-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3892\/ijmm.2015.2430","article-title":"Damage to dopaminergic neurons is mediated by proliferating cell nuclear antigen through the p53 pathway under conditions of oxidative stress in a cell model of Parkinson's disease","volume":"37","author":"Li","year":"2016","journal-title":"Int J Mol Med"},{"key":"key20180108030128_b7-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1093\/nar\/gkp357","article-title":"Role of PCNA-dependent stimulation of 3\u2032-phosphodiesterase and 3\u2032-5\u2032 exonuclease activities of human Ape2 in repair of oxidative DNA damage","volume":"37","author":"Burkovics","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"key20180108030128_b8-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1105\/tpc.110.081455","article-title":"Oxidative DNA damage bypass in Arabidopsis thaliana requires DNA polymerase \u03bb and proliferating cell nuclear antigen 2","volume":"23","author":"Amoroso","year":"2011","journal-title":"Plant Cell"},{"key":"key20180108030128_b9-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.bbagen.2009.07.026","article-title":"Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential","volume":"1790","author":"Shay","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"key20180108030128_b10-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1093\/jn\/133.11.3327","article-title":"Alpha-lipoic acid and cardiovascular disease","volume":"133","author":"Wollin","year":"2003","journal-title":"J Nutr"},{"key":"key20180108030128_b11-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1476-511X-10-217","article-title":"Effect of \u03b1-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance","volume":"10","author":"McNeilly","year":"2011","journal-title":"Lipids Health Dis"},{"key":"key20180108030128_b12-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1089\/jmf.2013.0111","article-title":"The effects of \u03b1-lipoic acid on liver oxidative stress and free fatty acid composition in methionine-choline deficient diet-induced NAFLD","volume":"17","author":"Stankovi\u0107","year":"2014","journal-title":"J Med Food"},{"key":"key20180108030128_b13-mmr-14-05-4360","first-page":"181","article-title":"Total oxidative status of mouse vitrified pre-antral follicles with pre-treatment of alpha lipoic acid","volume":"18","author":"Hatami","year":"2014","journal-title":"Iran Biomed J"},{"key":"key20180108030128_b14-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"634515","DOI":"10.1155\/2014\/634515","article-title":"Effect of \u03b1-lipoic acid on oxidative stress in end-stage renal disease patients receiving intravenous iron","volume":"2014","author":"Showkat","year":"2014","journal-title":"ISRN Nephrol"},{"key":"key20180108030128_b15-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/BF00400603","article-title":"Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)","volume":"38","author":"Ziegler","year":"1995","journal-title":"Diabetologia"},{"key":"key20180108030128_b16-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.2337\/diacare.22.8.1296","article-title":"Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III study group. Alpha-lipoic acid in diabetic neuropathy","volume":"22","author":"Ziegler","year":"1999","journal-title":"Diabetes Care"},{"key":"key20180108030128_b17-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/jcbfm.2013.196","article-title":"Reversal of metabolic deficits by lipoic acid in a triple transgenic mouse model of Alzheimer's disease: A 13C NMR study","volume":"34","author":"Sancheti","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"key20180108030128_b18-mmr-14-05-4360","first-page":"25","article-title":"Protective effects of lipoic acid on chrysene-induced toxicity on M\u00fcller cells in vitro","volume":"19","author":"Mansoor","year":"2013","journal-title":"Mol Vis"},{"key":"key20180108030128_b19-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3892\/ijmm.2013.1361","article-title":"\u03b1-lipoic acid protects dopaminergic neurons against MPP+-induced apoptosis by attenuating reactive oxygen species formation","volume":"32","author":"Li","year":"2013","journal-title":"Int J Mol Med"},{"key":"key20180108030128_b20-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1073\/pnas.93.2.895","article-title":"Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53","volume":"93","author":"Morris","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108030128_b21-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1128\/MCB.15.12.6785","article-title":"Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter","volume":"15","author":"Shivakumar","year":"1995","journal-title":"Mol Cell Biol"},{"key":"key20180108030128_b22-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1006\/nbdi.2000.0314","article-title":"p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis","volume":"7","author":"Martin","year":"2000","journal-title":"Neurobiol Dis"},{"key":"key20180108030128_b23-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.10350","article-title":"p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism","volume":"52","author":"Duan","year":"2002","journal-title":"Ann Neurol"},{"key":"key20180108030128_b24-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson's disease","volume":"55","author":"Forno","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"key20180108030128_b25-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson's disease","volume":"3","author":"Dias","year":"2013","journal-title":"J Parkinsons Dis"},{"key":"key20180108030128_b26-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.chemphyslip.2003.10.010","article-title":"Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases","volume":"128","author":"Montine","year":"2004","journal-title":"Chem Phys Lipids"},{"key":"key20180108030128_b27-mmr-14-05-4360","first-page":"S64","article-title":"Iron and brain disorders","volume":"121","author":"Sadrzadeh","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"key20180108030128_b28-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tox.2011.03.001","article-title":"Advances in metal-induced oxidative stress and human disease","volume":"283","author":"Jomova","year":"2011","journal-title":"Toxicology"},{"key":"key20180108030128_b29-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-211-33328-0_7","article-title":"Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: Possible implications of glial cells","author":"Nagatsu","year":"2006","journal-title":"J Neural Transm Suppl"},{"key":"key20180108030128_b30-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10534-012-9523-0","article-title":"Iron toxicity in neurodegeneration","volume":"25","author":"N\u00fa\u00f1ez","year":"2012","journal-title":"Biometals"},{"key":"key20180108030128_b31-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1734-1140(11)70600-4","article-title":"Lipoic acid-biological activity and therapeutic potential","volume":"63","author":"Goraca","year":"2011","journal-title":"Pharmacol Rep"},{"key":"key20180108030128_b32-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(96)00009-1","article-title":"Alpha-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats","volume":"717","author":"Panigrahi","year":"1996","journal-title":"Brain Res"},{"key":"key20180108030128_b33-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0531-5565(02)00015-3","article-title":"Effect of DL-alpha-lipoic acid on the status of lipid peroxidation and antioxidant enzymes in various brain regions of aged rats","volume":"37","author":"Arivazhagan","year":"2002","journal-title":"Exp Gerontol"},{"key":"key20180108030128_b34-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.cdd.4401908","article-title":"Dissecting p53-dependent apoptosis","volume":"13","author":"Chipuk","year":"2006","journal-title":"Cell Death Differ"},{"key":"key20180108030128_b35-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bbrc.2005.03.149","article-title":"p53 in neuronal apoptosis","volume":"331","author":"Culmsee","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108030128_b36-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1471-4159.2002.01144.x","article-title":"A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism","volume":"83","author":"Mandir","year":"2002","journal-title":"J Neurochem"},{"key":"key20180108030128_b37-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10495-006-6316-3","article-title":"Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson's disease","volume":"11","author":"Nair","year":"2006","journal-title":"Apoptosis"},{"key":"key20180108030128_b38-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11064-005-6877-5","article-title":"Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease","volume":"30","author":"Biswas","year":"2005","journal-title":"Neurochem Res"},{"key":"key20180108030128_b39-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neulet.2003.10.048","article-title":"p53-mediated mitochondrial dysfunction by proteasome inhibition in dopaminergic SH-SY5Y cells","volume":"354","author":"Nakaso","year":"2004","journal-title":"Neurosci Lett"},{"key":"key20180108030128_b40-mmr-14-05-4360","first-page":"829","article-title":"Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo","volume":"42","author":"Busse","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"key20180108030128_b41-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10815-011-9706-6","article-title":"The effect of alpha lipoic acid on the developmental competence of mouse isolated preantral follicles","volume":"29","author":"Talebi","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"key20180108030128_b42-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0891-5849(95)00017-R","article-title":"Alpha-Lipoic acid as a biological antioxidant","volume":"19","author":"Packer","year":"1995","journal-title":"Free Radic Biol Med"},{"key":"key20180108030128_b43-mmr-14-05-4360","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0891-5849(96)00269-9","article-title":"Neuroprotection by the metabolic antioxidant alpha-lipoic acid","volume":"22","author":"Packer","year":"1997","journal-title":"Free Radic Biol Med"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2016.5754\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T04:25:02Z","timestamp":1601094302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2016.5754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,20]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,9,20]]},"published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.3892\/mmr.2016.5754"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2016.5754","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,20]]}}}